114 related articles for article (PubMed ID: 7887648)
1. [Dynamic change of serum UFT concentration in a patient with tongue cancer complicating chronic renal failure].
Yanagisawa T; Arimoto T; Kishimoto H; Takahashi Y; Urade M; Yoshioka W
Gan To Kagaku Ryoho; 1995 Mar; 22(4):553-6. PubMed ID: 7887648
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetic study of UFT in cancer patients receiving maintenance dialysis].
Sakamoto K; Arita S; Hisikawa E; Yaguchi H; Arima H; Matsumoto M; Hachisu T; Kashiwabara H; Yokoyama T
Gan To Kagaku Ryoho; 1995 Feb; 22(2):239-44. PubMed ID: 7857099
[TBL] [Abstract][Full Text] [Related]
3. [5-FU, FT-207 and uracil concentrations in the serum and tissues of patients with cervical cancer after UFT oral administration].
Tanimura T; Kaneshige E; Fujiwara K; Kobashi Y; Inoue K; Kono I; Sekiba K
Gan To Kagaku Ryoho; 1986 Feb; 13(2):349-55. PubMed ID: 3080967
[TBL] [Abstract][Full Text] [Related]
4. [5-FU concentration in blood and tissue of patients with renal cell carcinoma after administration of UFT].
Masuda F; Suzuki M; Ohnishi T; Nakada J; Mori Y; Iizuka N; Machida T
Gan To Kagaku Ryoho; 1985 Feb; 12(2):320-4. PubMed ID: 3918507
[TBL] [Abstract][Full Text] [Related]
5. [A study of urinary tegafur, 5-fluorouracil (5-FU) and uracil concentrations in the cases of gastric carcinoma for the confirmation of drug-taking compliance after UFT oral administration].
Ohsawa S; Kondo Y; Shiroto H; Masuko H; Fukushima T; Kataoka A; Ohmori K; Sawaguchi Y; Baba E; Takahashi T
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2189-93. PubMed ID: 1444485
[TBL] [Abstract][Full Text] [Related]
6. [Portal-transfer of an orally administered anti-cancer agent analysis of the time course of portal blood and systemic blood levels of preoperatively administered UFT].
Yoshikawa K; Hashimoto T; Yamaguchi T; Dousei T; Moriguchi S; Taniguchi M; Ueda H; Taketani S; Utsumi T; Suhara H
Gan To Kagaku Ryoho; 1994 Mar; 21(4):501-5. PubMed ID: 8129391
[TBL] [Abstract][Full Text] [Related]
7. [5-FU concentration in blood and tissue of patients with primary lung cancer after oral administration of UFT].
Oiwa T; Saito H
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):525-30. PubMed ID: 3082289
[TBL] [Abstract][Full Text] [Related]
8. [Study on the concentrations of 5-fluorouracil (5-FU), tegafur (ET) and uracil in bile: comparison of UFT or FT].
Tomita T; Tajima T; Ishibashi M; Tagaya N; Aoki H; Itoh S; Kadowaki A; Kogure H; Tajima Y
Gan To Kagaku Ryoho; 1989 Dec; 16(12):3755-62. PubMed ID: 2512859
[TBL] [Abstract][Full Text] [Related]
9. [The serum and tissue concentrations of tegafur, 5-fluorouracil and uracil in patients with gastric and colorectal cancers after oral administration of UFT].
Takahashi N; Nitta A; Saitou T; Mori Y; Kunii Y; Kikuchi K
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2319-23. PubMed ID: 3136701
[TBL] [Abstract][Full Text] [Related]
10. [Blood concentrations of futraful, uracil and 5-fluorouracil (5-FU) after UFT administration in the various reconstructions after gastrectomy. Saitama UFT Research Group].
Suda Y; Uchida K; Okamura H; Oshima Y; Shimizu M; Miyakawa T; Okubo S; Shiina E; Hosoda Y; Tokura Y
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2181-7. PubMed ID: 1444484
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of long-term administration of oral anti-cancer agent].
Watanabe H; Sakakibara N
Gan To Kagaku Ryoho; 1993 Apr; 20(5):637-42. PubMed ID: 8470922
[TBL] [Abstract][Full Text] [Related]
12. [Level of 5-FU in cancerous and normal tissues of nude mice after oral administration of tegafur coadministered with uracil (UFT)].
Sekiguchi I; Suzuki M; Tamada T; Nishida M
Gan To Kagaku Ryoho; 1985 May; 12(5):1094-8. PubMed ID: 3922312
[TBL] [Abstract][Full Text] [Related]
13. [Effects of combination chemotherapy with topical application of 5-FU ointment to mice's tongue and UFT].
Tateishi A; Sakaki Y; Kameyama Y; Hara I; Yamada N
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1877-85. PubMed ID: 2118335
[TBL] [Abstract][Full Text] [Related]
14. [FT, 5-FU and uracil concentrations of the blood, bile and tissue of hepatoma with liver cirrhosis after oral administration of UFT].
Oguma S; Sakai K; Sato R; Ouchi K; Owada Y; Sato T
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1122-8. PubMed ID: 3032114
[TBL] [Abstract][Full Text] [Related]
15. [The effect of gastrectomy on serum 5-FU concentrations of patients administered UFT per os].
Yamamoto Y; Amano T; Fujimoto Y; Imada T; Tamura S; Noguchi Y; Matsumoto A
Gan No Rinsho; 1987 Apr; 33(4):377-81. PubMed ID: 3106673
[TBL] [Abstract][Full Text] [Related]
16. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M
Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
[TBL] [Abstract][Full Text] [Related]
17. [UFT concentration in serum and tissues of patients with gynecologic malignant tumors following oral administration].
Inoue S; Shibata S; Okumura A; Tanaka T; Onitsuka Y; Yoshimura T; Aiko A; Ikuta Y; Fukuma K; Matsuura K
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):499-504. PubMed ID: 3923940
[TBL] [Abstract][Full Text] [Related]
18. [Level of 5-FU in uterine cervical cancer tissue after oral administration of UFT].
Suzuki M; Sekiguchi I; Ohwada M; Tamada T
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2139-44. PubMed ID: 3933435
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
[TBL] [Abstract][Full Text] [Related]
20. [5-Fluorouracil, tegafur, and uracil concentrations in serum and tissue of the patients with hepatocellular carcinoma after UFT administration].
Suenaga M
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3313-8. PubMed ID: 2825604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
